Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
暂无分享,去创建一个
Simone Schrading | Sven Nebelung | Robin Bruhn | Nils Krämer | C. Kuhl | S. Nebelung | A. Heidenreich | S. Schrading | Christiane K Kuhl | Axel Heidenreich | Nils Krämer | Robin Bruhn
[1] P. Dean,et al. Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial) , 2017, Journal of magnetic resonance imaging : JMRI.
[2] Jason D. Wright,et al. Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States , 2017, JAMA oncology.
[3] Adam T Froemming,et al. The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy. , 2017, European urology.
[4] A. Vickers,et al. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study. , 2017, European urology.
[5] David D. Casalino,et al. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer , 2017, Abdominal Radiology.
[6] Arturo Brunetti,et al. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? , 2016, European journal of radiology.
[7] D. Margolis,et al. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. , 2016, The Journal of urology.
[8] M. Roethke,et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. , 2016, European urology.
[9] H. D. de Koning,et al. Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis , 2016, Cancer.
[10] A. Auvinen,et al. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC) , 2016, BJU international.
[11] P. Mozer,et al. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer? , 2016, The Journal of urology.
[12] J. Hugosson,et al. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial. , 2016, European urology.
[13] H. Thomsen,et al. Biparametric versus multiparametric MRI in the diagnosis of prostate cancer , 2016, Acta radiologica open.
[14] Rajan T. Gupta,et al. Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer. , 2016, European urology.
[15] J Alfred Witjes,et al. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. , 2016, European urology.
[16] S. Taneja. Re: Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-Guided In-Bore Biopsy to MRI-Ultrasound Fusion and Transrectal Ultrasound-Guided Prostate Biopsy in Patients with Prior Negative Biopsies. , 2016, The Journal of urology.
[17] Dorothy A. Sippo,et al. An Abbreviated Protocol for High-Risk Screening Breast MRI Saves Time and Resources. , 2016, Journal of the American College of Radiology : JACR.
[18] Fang-Ming Deng,et al. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. , 2016, European urology.
[19] Saila Kauppila,et al. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. , 2016, European urology.
[20] P. Choyke,et al. Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population. , 2016, Urology.
[21] J. Fütterer,et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.
[22] A. Jemal,et al. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. , 2015, JAMA.
[23] H. D. de Koning,et al. Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer. , 2015, European urology.
[24] Sora C. Yoon,et al. Abbreviated screening protocol for breast MRI: a feasibility study. , 2015, Academic radiology.
[25] H. Merisaari,et al. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy , 2015, Journal of magnetic resonance imaging : JMRI.
[26] F. Beuvon,et al. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? , 2015, The Journal of urology.
[27] P. Choyke,et al. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate‐specific antigen (PSA)‐based detection of prostate cancer in men without prior biopsies , 2015, BJU international.
[28] Baris Turkbey,et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.
[29] T. Tammela,et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up , 2014, The Lancet.
[30] X Wang,et al. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T. , 2014, Clinical radiology.
[31] Ralf-Dieter Hilgers,et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] F. Schröder,et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.
[33] Chen Jie,et al. The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis , 2014, European Radiology.
[34] Shyam Natarajan,et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.
[35] Marco Salvatore,et al. Comparison Between Gleason Score and Apparent Diffusion Coefficient Obtained from Diffusion-Weighted Imaging of Prostate Cancer Patients , 2013, Cancer investigation.
[36] Walter Artibani,et al. Early detection of prostate cancer: European Association of Urology recommendation. , 2013, European urology.
[37] A. Partin,et al. Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system. , 2012, Urology.
[38] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[39] Lars Egevad,et al. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. , 2012, European urology.
[40] C. Parker,et al. Multiparametric magnetic resonance imaging in the diagnosis and characterisation of prostate cancer: The PROMIS study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[42] Jelle O. Barentsz,et al. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours , 2012, European Radiology.
[43] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[44] P. Choyke,et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.
[45] A. D'Amico,et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.
[46] Heinz-Peter Schlemmer,et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.
[47] B. Konety,et al. Prevalence of prostate specific antigen testing for prostate cancer in elderly men. , 2006, The Journal of urology.
[48] Hartwig Huland,et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. , 2003, The Journal of urology.
[49] John E Tomaszewski,et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era , 2002, Cancer.